@FierceBiotech: Polaris preps for a $400M fund to back a new wave of biotechs. More | Follow @FierceBiotech
@JohnCFierce: Biotech vets target $43M round to debut new antifungal venture. Story | Follow @JohnCFierce
@DamianFierce: We need to commission an inversion graphic for future stories. Article | Follow @DamianFierce
@EmilyMFierce: Gives a new meaning to YOLO: The Higgs Boson should have crushed the universe. More | Follow @EmilyMFierce
> In a Phase II trial, Agenus' ($AGEN) herpes vaccine led to an immune responses in more than half of patients and notched a statistically significant 75% reduction in viral load in that population. More
> The U.K.'s 4d Pharma, which recently went public, raised £21.5 million ($36.6 million) in a stock offering. News
> The recently IPO'd ZS Pharma ($ZSPH) has kicked off enrollment in its Phase III trial of ZS-9, an investigational treatment for the kidney disease hyperkalemia. Item
Medical Device News
@FierceMedDev: Check out our newest special report: Top 10 med tech R&D budgets. Read | Follow @FierceMedDev
@StacyALawrence: Newly public Inogen gains on FDA clearance for home oxygen device. Story | Follow @StacyALawrence
@MichaelGFierce: Intersect ENT files for $80M IPO to support steroid-delivering sinus implants. More via FierceDrugDelivery | Follow @MichaelGFierce
@EmilyWFierce: Ultrasound therapy outfit rakes in $2M for wearable chronic pain device. Story | Follow @EmilyWFierce
> Danaher demurs on M&A, looks to China, Brazil and Russia. Piece
> $125M IPO planned for former BMS medical imaging unit. News
Pharma News
@FiercePharma: Special: The top 5 vaccines by 2020. Report | Follow @FiercePharma
@TracyStaton: Here's @JohnCFierce's take on the Vertex VX-809/Kalydeco PhIII, including interview with CEO Jeff Leiden. Story | Follow @TracyStaton
@EricPFierce: Actavis says growing production at plant in Malta called for new warehouse. More | Follow @EricPFierce
@CarlyHFierce: Here's this week's issue of FierceVaccines. Hint: It's a good one. Issue | Follow @CarlyHFierce
> Eli Lilly's anti-takeover superpower? A shield forged by Indiana lawmakers. Story
> Biogen MS blockbuster Tecfidera earns high marks for safety. Article
> Reuters: Valeant supporter Paulson grabs 6 million-plus Allergan shares. More
> After 4-year Benicar review, FDA slaps aside heart-risk worries. News
Vaccines News
> Italian officials probe Novartis for possible flu vaccine pricing fraud. Story
> FDA slaps Glaxo with warning letter for FluLaval plant. More
> CDC committee recommends AZ's FluMist over flu shot in children. Article
> The top 5 vaccines by 2020. Report
> Feds charge researcher in HIV vaccine fraud case. More
> Reuters: Sanofi plans to put dengue program into separate unit. News
Pharma Manufacturing News
> FDA finds contamination issues at GSK vax plant. More
> India production expert urges excellence from drugmakers. Story
> New Indian government looks to help small players finance upgrades. Article
> Sanofi buys Dubai's Globalpharma to produce generics in the Middle East. News
> Actavis opens $18M warehouse on Malta. Report